Local Radiation Therapy for Bladder Cancer Not Suitable for Surgery
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether focused radiation therapy directed at the bladder can help patients with muscle-invasive bladder cancer who are not candidates for surgical removal or have chosen not to have surgery. The goal is to see if this approach can control the cancer and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with muscle-invasive urothelial bladder cancer (a common type of bladder cancer that has grown into the muscle layer)
- Your medical team has determined you are not a good candidate for curative treatment (surgery to remove the bladder), or you have chosen not to have this surgery
- You are at least 18 years old
- You have not had previous radiation therapy to the pelvis (lower abdomen), or any previous radiation does not significantly overlap with the treatment area
- You do not have cancer that has spread to distant organs (liver, lungs, bones) or multiple enlarged lymph nodes
- You are not currently scheduled to receive chemotherapy at the time you would start this trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well radiation therapy works as the main treatment for bladder cancer. It aims to help patients understand the outcomes of this treatment approach.
This trial tests a new type of radiation therapy that adjusts to your body's changes during treatment. It aims to reduce side effects and improve accuracy for people with bladder cancer.
This trial tests whether radiation therapy (high-energy beams to kill cancer cells) can be a good treatment for bladder cancer that hasn't gone away after BCG therapy, offering an alternative to surgery to remove the bladder. It aims to see if this approach can control the cancer while possibly preserving your bladder.
This trial tests whether radiation therapy can help people with early-stage bladder cancer that has a high risk of coming back. It may be an option for those who have not tried BCG treatment.
This trial tests radiotherapy (high-energy X-rays) for a specific type of early-stage bladder cancer (CIS) that hasn't gone away after BCG treatment. It's for people who can't or choose not to have bladder removal surgery.
This trial tests whether giving focused radiation (SBRT) to a few remaining metastatic spots can stop bladder cancer from progressing after initial chemotherapy or immunotherapy has worked. It may help patients who still have up to three remaining distant lesions but are not getting worse.
Hear when a new Bladder Cancer (BC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.